Patents by Inventor David G. Osterman

David G. Osterman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for assaying enzyme activity
    Patent number: 6994956
    Abstract: The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.
    Type: Grant
    Filed: August 4, 2004
    Date of Patent: February 7, 2006
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: James A. Landro, David G. Osterman, Walter Pickett
  • Aminomethylene derivaties as immunosuppressants
    Patent number: 5686469
    Abstract: Compounds which suppress human T-lymphocyte proliferation are disclosed.
    Type: Grant
    Filed: December 12, 1995
    Date of Patent: November 11, 1997
    Assignee: Miles Inc.
    Inventors: Richard D. Connell, David G. Osterman, Michael E. Katz, Robert D. Dally
  • 2-oxoethyl derivatives as immunosuppressants
    Patent number: 5686424
    Abstract: A class of compounds that suppress human T-lymphocyte proliferation is disclosed.
    Type: Grant
    Filed: April 28, 1995
    Date of Patent: November 11, 1997
    Assignee: Miles Inc.
    Inventors: Richard D. Connell, David G. Osterman, Michael E. Katz
  • Sulfonamide aminomethylene derivatives as immunosuppressants
    Patent number: 5633277
    Abstract: Compounds which suppress human T-lymphocyte proliferation are disclosed.
    Type: Grant
    Filed: September 26, 1995
    Date of Patent: May 27, 1997
    Assignee: Miles Inc.
    Inventors: Richard D. Connell, David G. Osterman, Michael E. Katz, Robert D. Dally
  • Aminomethylene-peptides as immunosuppressants
    Patent number: 5385918
    Abstract: Compounds which suppress human T-lymphocyte proliferation are disclosed. The active compounds essentially contain at least the following structure: ##STR1## wherein A, R.sup.1, R.sup.2, R.sup.3, n, X.sup.1 and Z are defined in the specification.
    Type: Grant
    Filed: February 9, 1993
    Date of Patent: January 31, 1995
    Assignee: Miles Inc.
    Inventors: Richard D. Connell, David G. Osterman, Michael E. Katz, Rudolf Hanko, Stephan Schneider